does cvs caremark cover glp 1 for weight loss stopped covering a GLP-1 obesity. Now there's a lawsuit CVS Caremark expands access to
Description
Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S
Provider-supervised GLP-1 weight loss via telehealth
Led by graduate student Jordan Miller '25 and Professor David Han, the team studied national poison control center data and identified a sharp rise in semaglutide-related calls following the FDAs 2021 approval of the medication for chronic weight management
Non-GLP-1 weight loss medications offer alternatives for patients who cannot tolerate GLP-1 agents or require different mechanisms of action
